FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18401611000001102: Rapamune 0.5mg tablets (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Feb 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62798701000001113 Rapamune 0.5mg tablets (Pfizer Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62798801000001116 Rapamune 0.5mg tablets (Pfizer Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rapamune 0.5mg tablets (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rapamune 0.5mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rapamune 0.5mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rapamune 0.5mg tablets (Pfizer Ltd) Is a Sirolimus 500microgram tablets true Inferred relationship Existential restriction modifier
Rapamune 0.5mg tablets (Pfizer Ltd) Has active ingredient Sirolimus true Inferred relationship Existential restriction modifier
Rapamune 0.5mg tablets (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rapamune 0.5mg tablets (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rapamune 0.5mg tablets (Pfizer Ltd) Has specific active ingredient Sirolimus true Inferred relationship Existential restriction modifier
Rapamune 0.5mg tablets (Pfizer Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rapamune 0.5mg tablets (Pfizer Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Rapamune 0.5mg tablets (Pfizer Ltd) Is a Rapamune true Inferred relationship Existential restriction modifier
Rapamune 0.5mg tablets (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rapamune 0.5mg tablets (Pfizer Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Rapamune 0.5mg tablets (Pfizer Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rapamune 0.5mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has AMP True Rapamune 0.5mg tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start